Investment marks continued progress against AbbVie’s $100 billion commitment to U.S. research and development (R&D) and capital investments, including manufacturing, over the next decadeRead More
AbbVie to Invest 380 Million in North Chicago to Further Expand Active Pharmaceutical Ingredient Manufacturing in the United States AbbVie News Center
